| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CNR1 |
CNR1, CNR: Cannabinoid receptor 1 |
0.745 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
C1QTNF5 |
C1QTNF5, CTRP5, UNQ303/PRO344: Complement C1q tumor necrosis factor-related prot |
0.745 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
DUSP10 |
DUSP10, MKP5: Dual specificity protein phosphatase 10 |
0.745 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
OR8B8 |
OR8B8: Olfactory receptor 8B8 |
0.745 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
PRLHR |
PRLHR, GPR10, GR3: Prolactin-releasing peptide receptor |
0.745 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
0.745 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.745 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
OR8B8 |
OR8B8: Olfactory receptor 8B8 |
0.745 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
GPR103 |
GPR103: Orexigenic neuropeptide QRFP receptor |
0.745 |
Evidence |
|
| OPN1MW |
OPN1MW, GCP: Green-sensitive opsin |
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
0.745 |
Evidence |
|
| OPN1LW |
OPN1LW, RCP: Red-sensitive opsin |
GPR92 |
GPR92, GPR93: Probable G-protein coupled receptor 92 |
0.745 |
Evidence |
|
| OPN1LW |
OPN1LW, RCP: Red-sensitive opsin |
OR11A1 |
OR11A1, OR11A2: Olfactory receptor 11A1 |
0.745 |
Evidence |
|
| OPN1LW |
OPN1LW, RCP: Red-sensitive opsin |
HTR4 |
HTR4: 5-hydroxytryptamine receptor 4 |
0.745 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
FSTL5 |
FSTL5, KIAA1263: Follistatin-related protein 5 precursor |
0.745 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
ADAMTS17 |
ADAMTS17: ADAMTS-17 precursor |
0.745 |
Evidence |
|
| SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
REG3G |
REG3G, PAP1B, UNQ429/PRO162: Regenerating islet-derived protein 3 gamma precurso |
0.745 |
Evidence |
|
| CFB |
CFB, BF, BFD: Complement factor B precursor |
PSG11 |
PSG11, PSG13, PSG14: Pregnancy-specific beta-1-glycoprotein 11 precursor |
0.745 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
C1QTNF7 |
IPI00011096 |
0.745 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
C1QTNF5 |
C1QTNF5, CTRP5, UNQ303/PRO344: Complement C1q tumor necrosis factor-related prot |
0.745 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
COL6A2 |
COL6A2: Collagen alpha-2(VI) chain precursor |
0.745 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
PMS2 |
PMS2: Postmeiotic segregation increased 2 nirs variant 1 |
0.745 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
0.745 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
OR8B8 |
OR8B8: Olfactory receptor 8B8 |
0.745 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
C9orf47 |
EDG3: Sphingosine 1-phosphate receptor Edg-3 |
0.745 |
Evidence |
|